Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19
Annals of Internal Medicine · 2023-04 · 176 (4) · 505-514
DOI: 10.7326/m22-3057 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Annals of Internal Medicine, 2023-04. Verfasst von Eric Yuk Fai Wan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Ko…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Laboratory of Data Discovery for Health (D24H), Hong Kong Science…
- Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (V.K.C.Y., F.W.T.C.).
- Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (A.H.Y.M., B.W., W.X.).
- Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and Laboratory of Data Discovery for Health (D24H), Hong Kong Scie…
- Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and School of Public Health, Li Ka Shing Faculty of…
- Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (P.H.L., I.F.N.H., C.S.L.).
ORCID-Profile: Eric Yuk Fai Wan, Vincent Ka Chun Yan, Franco Wing Tak Cheng, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Philip Hei Li, Benjamin John Cowling, Ivan Fan Ngai Hung, Chak Sing Lau, Ian Chi Kei Wong, Esther Wai Yin Chan
Zitieren
APA
Wan, E. Y. F., Yan, V. K. C., Mok, A. H. Y., Wang, B., Xu, W., Cheng, F. W. T., Lai, F. T. T., Chui, C. S. L., Li, X., Wong, C. K. H., Li, P. H., Cowling, B. J., Hung, I. F. N., Lau, C. S., Wong, I. C. K., & Chan, E. W. Y. (2023). Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19. Annals of Internal Medicine, 176(4), 505-514. https://doi.org/10.7326/m22-3057
Vancouver
Wan EYF, Yan VKC, Mok AHY, Wang B, Xu W, Cheng FWT, et al. Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19. Annals of Internal Medicine. 2023;176(4):505-514. doi:10.7326/m22-3057
BibTeX
@article{Wan2023,
author = {Wan, Eric Yuk Fai and Yan, Vincent Ka Chun and Mok, Anna Hoi Ying and Wang, Boyuan and Xu, Wanchun and Cheng, Franco Wing Tak and Lai, Francisco Tsz Tsun and Chui, Celine Sze Ling and Li, Xue and Wong, Carlos King Ho and Li, Philip Hei and Cowling, Benjamin John and Hung, Ivan Fan Ngai and Lau, Chak Sing and Wong, Ian Chi Kei and Chan, Esther Wai Yin},
title = {Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19},
journal = {Annals of Internal Medicine},
year = {2023},
volume = {176},
number = {4},
pages = {505--514},
doi = {10.7326/m22-3057}
}
EUVIMED